China Medical System Holdings Limited (OTCMKTS:CHSYF) Sees Large Decrease in Short Interest

China Medical System Holdings Limited (OTCMKTS:CHSYFGet Free Report) was the recipient of a significant decline in short interest in the month of November. As of November 15th, there was short interest totalling 20,000 shares, a decline of 94.7% from the October 31st total of 374,900 shares. Based on an average daily volume of 3,800 shares, the days-to-cover ratio is currently 5.3 days.

China Medical System Price Performance

CHSYF remained flat at $0.93 during mid-day trading on Thursday. The stock’s fifty day simple moving average is $0.93 and its 200-day simple moving average is $0.93. China Medical System has a fifty-two week low of $0.93 and a fifty-two week high of $0.93.

China Medical System Company Profile

(Get Free Report)

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. The company's products include Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu for the treatment of acute heart failure; Deanxit for the treating mild-to-moderate depression, anxiety, and psychosomatic affections; Ursofalk for the treatment of cholesterol gallstones in the gallbladder, cholestatic liver disease, and biliary reflux gastritis; Salofalk for treating Ulcerative Colitis and Crohn's disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; Augentropfen Stulln Mono eye drops to treat senile macula degeneration and asthenopia; and Hirudoid for blunt traumata with or without hematomas and superficial phlebitis insofar.

Read More

Receive News & Ratings for China Medical System Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Medical System and related companies with MarketBeat.com's FREE daily email newsletter.